Division of Stroke and Critical Care CUMC NINY
Endovascular GDC Coil Treatment for Poor Grade, High Risk patients with Subarachnoid Hemorrhage (SAH)


   

Principal Investigator: Dr.Gary L. Bernardini
Department of Neurology
Division of Critical Care Neurology

Co-Investigators:
Dr. Stephan Mayer
Department of Neurology
Division of Critical Care Neurology
Dr. John Pile-Spellman
Department of Radiology and Neurosurgery
This is a retrospective study designed to evaluate the efficacy and outcome of treatment of recently ruptured intracranial aneurysms with Guglielmi detachable coil (GDC) emolization in patients with subarachnoid hemorrhage (SAH).

Over a three year period twenty patients receiving GDC embolization were studied. Initial clinical assessment and outcomes were determined by admission and worst Hunt & Hess scores, Glasgow Coma Score, NIH Stroke Scale, APACHE II scores, Glasgow Outcome Scale (at 30 days and 6 months), and overal disposition. The data collected indicates that endovascular GDC coil embolization successfully prevents rebleeding complications of SAH and allows induced hypertension in poor risk patients with inoperable intracranial aneurysms.

©2004-2006 The Neurological Institute of New York • Affiliated with New York-Presbyterian Hospital
• Columbia University Medical Center • Division of Stroke and Critical Care • 710 W 168th St, New York, NY 10032
Updated September 6, 2006
Comments